Primary prevention of rheumatic fever in children: Key factors to consider

Andrew Steer; Margie Danchin; James H Irlam; Bongani M Mayosi; Mark E Engel; Thomas A Gaziano; Andrew C Whitelaw

doi:10.7196/SAMJ.7880

Correspondence

Primary prevention of rheumatic fever in children: Key factors to consider

Andrew Steer, Margie Danchin, James H Irlam, Bongani M Mayosi, Mark E Engel, Thomas A Gaziano, Andrew C Whitelaw

Abstract

Authors' affiliations

Andrew Steer, Centre for International Child Health, Department of Paediatrics, and Department of General Medicine, Royal Children’s Hospital, Melbourne, Australia; Group A Streptococcal Research Group, Murdoch Childrens Research Institute, Melbourne, Australia

Margie Danchin, Department of General Medicine, Royal Children’s Hospital, Melbourne, Australia; Group A Streptococcal Research Group, and Vaccine and Immunisation Research Group, Murdoch Childrens Research Institute, Melbourne, Australia

James H Irlam, Primary Health Care Directorate, University of Cape Town, South Africa

Bongani M Mayosi, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa

Mark E Engel, Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa

Thomas A Gaziano, Department of Cardiology, Brigham and Women’s Hospital, Boston, USA

Andrew C Whitelaw, Department of Microbiology, Tygerberg Hospital and National Health Laboratory Service, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa